| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +41 | +4% | $0.000000 | 1,068 | 01 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $6,708 | -17 | -1.6% | $394.60 | 1,051 | 01 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +30 | +2.9% | $0.000000 | 1,081 | 01 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $4,735 | -12 | -1.1% | $394.60 | 1,069 | 01 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +44 | +4.1% | $0.000000 | 1,113 | 02 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $7,103 | -18 | -1.6% | $394.60 | 1,095 | 02 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +56 | +5.1% | $0.000000 | 1,151 | 03 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $9,076 | -23 | -2% | $394.60 | 1,128 | 03 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +82 | +7.3% | $0.000000 | 1,210 | 04 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $13,416 | -34 | -2.8% | $394.60 | 1,176 | 04 Sep 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Restricted Stock Units | Award | $0 | +298 | $0.000000 | 298 | 01 Sep 2023 | Bio-Rad A Common Stock | 298 | $0.000000 | Direct | F2, F3 | |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -41 | -25% | $0.000000 | 126 | 01 Sep 2023 | Bio-Rad A Common Stock | 41 | $0.000000 | Direct | F2, F4 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -30 | -33% | $0.000000 | 62 | 01 Sep 2023 | Bio-Rad A Common Stock | 30 | $0.000000 | Direct | F2, F5 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -44 | -50% | $0.000000 | 44 | 02 Sep 2023 | Bio-Rad A Common Stock | 44 | $0.000000 | Direct | F2, F6 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -56 | -50% | $0.000000 | 56 | 03 Sep 2023 | Bio-Rad A Common Stock | 56 | $0.000000 | Direct | F2, F7 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -82 | -100% | $0.000000* | 0 | 04 Sep 2023 | Bio-Rad A Common Stock | 82 | $0.000000 | Direct | F2, F8 |
| Id | Content |
|---|---|
| F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
| F3 | The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| F4 | On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F5 | On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F6 | On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F7 | On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
| F8 | On September 4, 2018, the reporting person was granted 410 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |